Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Total Debt (2020 - 2021)

Tenax Therapeutics' Total Debt history spans 3 years, with the latest figure at $3.0 million for Q2 2013.

  • On a quarterly basis, Total Debt rose 120.0% to $3.0 million in Q2 2013 year-over-year; TTM through Apr 2013 was $3.0 million, a 120.0% increase, with the full-year FY2013 number at $3.0 million, up 120.0% from a year prior.
  • Total Debt hit $3.0 million in Q2 2013 for Tenax Therapeutics, up from $2.6 million in the prior quarter.
  • Over the last five years, Total Debt for TENX hit a ceiling of $6.2 million in Q4 2011 and a floor of $952777.0 in Q1 2012.
  • Historically, Total Debt has averaged $3.1 million across 3 years, with a median of $2.6 million in 2013.
  • Biggest five-year swings in Total Debt: tumbled 69.51% in 2012 and later skyrocketed 171.43% in 2013.
  • Tracing TENX's Total Debt over 3 years: stood at $6.2 million in 2011, then tumbled by 64.75% to $2.2 million in 2012, then soared by 37.5% to $3.0 million in 2013.
  • Business Quant data shows Total Debt for TENX at $3.0 million in Q2 2013, $2.6 million in Q1 2013, and $2.2 million in Q4 2012.